BioCentury
ARTICLE | Financial News

Ariad completes follow-on

January 28, 2013 8:00 AM UTC

Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), Cambridge, Mass. Business: Cancer Date completed: 1/24/13 Type: Follow-on Raised: $300 million Shares: 15.3 million Price: $19.60 Shares after offering: 181.9...